YOUR CONTACT FOR:

The Biosimilars Group, Martin Blueggel

biosimilar development

Martin Blüggel
General Manager
The Biosimilars Group GmbH
Phone: +49 (0) 621 76449064
Email: Analytical_Development@TheBiosimilarsGroup.com

The Biosimilars Group, K. Matentzoglu

MANUFACTURING

Dr. Konstantin Matentzoglu
General Manager
The Biosimilars Group GmbH
Phone: +49 (0) 621 76449064
Email: Manufacturing@TheBiosimilarsGroup.com

The Biosimilars Group, Dr. Gundel Hager

NON-CLINICAL DEVELOPMENT

Dr. Gundel Hager
General Manager
The Biosimilars Group GmbH
Phone: +49 (0) 621 76449064
Email: Nonclinical@TheBiosimilarsGroup.com

The Biosimilars Group, Dr. Petra Kowalski

CLINICAL DEVELOPMENT

Dr. Petra Kowalski
The Biosimilars Group GmbH
Phone: +49 (0) 621 76449064
Email: Clinical@TheBiosimilarsGroup.com

The Biosimilars Group, Dr. Tilo Netzer

REGULATORY / PHARMACOVIGILANCE

Dr. Tilo Netzer
General Manager
The Biosimilars Group GmbH
Phone: +49 (0) 621 76449064
Email: Regulatory_PV@TheBiosimilarsGroup.com
The Biosimilars Group, Dr. Roland Meisel

GLOBAL BUSINESS DEVELOPMENT

Dr. Roland Meisel
The Biosimilars Group GmbH
Phone: +49 (0) 621 76449064
Email: Roland.Meisel@TheBiosimilarsGroup.com